Spersadex 0,1 % 1 mg/mL Sterile eye drops, solution.
PDF Leaflet Revision Date: 03 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various ocular inflammatory conditions.
Dosage (summary)
One drop, 4 times daily into the lower eyelid.
Special Populations
- Children under 2 years
- Diabetes
Pregnancy & Breastfeeding
Safety not established in pregnancy or breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Topical NSAIDs
Contraindications
- Hypersensitivity
- Corneal injuries
- Purulent infections
- Tuberculosis
- Mycoses
- Glaucoma
Common side effects
- Ocular discomfort
- Blurred vision
- Keratitis
- Conjunctivitis
Counselling Points
- Avoid contact lenses during treatment
- Monitor for visual disturbances
- Report lack of response within 48 hours
Serious warnings
- Prolonged use may cause glaucoma
- Risk of corneal perforation
- Cushingu2019s syndrome possible
Important Disclaimer
The Spersadex 0,1 % 1 mg/mL Sterile eye drops, solution. professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
